Ganglioside SSEA-4 in Ewing sarcoma marks a tumor cell population with aggressive features and is a potential cell-surface immune target.
Jamitzky S, Altvater B, Krekeler C, Hoen L, Brandes C, Ebbinghaus J, Richter L, Kosel L, Ochs L, Farwick N, Urban K, Kluge L, Bücker L, Görlich D, Johnston ICD, Pfeifer R, Hartmann W, Rossig C, Kailayangiri S.
Jamitzky S, et al. Among authors: urban k.
Sci Rep. 2024 May 24;14(1):11935. doi: 10.1038/s41598-024-62849-8.
Sci Rep. 2024.
PMID: 38789477
Free PMC article.